CRISPR Screen Data Analysis: From Raw Reads to Venn Diagram Intersection of Candidate Proteins

CRISPR screening has revolutionized functional genomics by enabling genome-wide interrogation of gene function. However, a successful screen does not end at the bench—CRISPR data analysis is where the actual discoveries happen. Researchers must transform millions of sequencing reads into a ranked list of candidate genes, then validate their findings through cross-comparison and intersection analysis.

One of the most common analytical challenges is comparing CRISPR screen results across multiple conditions, replicates, or analysis methods to identify consistently enriched or depleted hits. When you have 20 candidate proteins from one screen and need to compare them against results from another, a Venn diagram intersection provides an intuitive, quantitative visualization of overlapping and unique targets.
This guide walks through the complete CRISPR data analysis workflow—from raw sequencing reads to MAGeCK RRA analysis, candidate gene selection, and Venn diagram-based intersection comparison—so you can confidently identify high-confidence targets.
01
What Is CRISPR Screen Data Analysis?

The Core Goal: From Millions of Reads to a Handful of Targets

A typical pooled CRISPR screen generates millions of sequencing reads. Each read represents an sgRNA barcode from a specific cell in the screened population. The goal of CRISPR data analysis is to:
1. Count how many times each sgRNA appears in each sample
2. Compare sgRNA abundance between experimental and control conditions
3. Aggregate sgRNA-level changes to gene-level scores
4. Rank genes by statistical significance and effect size
5. Select candidate genes for downstream validation
The final output is typically a ranked list of genes—often the top 20 to 50 candidate proteins—that show significant enrichment (positive screen) or depletion (negative screen) in your experimental condition.

Why Data Analysis Is the Bottleneck of CRISPR Screening

While library design and cell screening are well-established, data analysis remains the most variable and error-prone step. Common challenges include:
• Insufficient sequencing depth leading to noisy sgRNA counts
• Low replicate correlation making it difficult to distinguish true hits from noise
• Ambiguous hit selection criteria (RRA rank vs. LFC + p-value threshold)
• Difficulty comparing results across screens to identify consistent targets
These challenges are precisely where Venn diagram intersection analysis becomes invaluable—it provides a visual and quantitative method for cross-screen comparison.

02
Step-by-Step CRISPR Data Analysis Workflow

Step 1: Sequencing Quality Control (QC)

Raw sequencing data (FASTQ files) must be filtered to remove adapter sequences and low-quality bases. Key QC metrics include:
Metric Threshold Purpose
Q20 >90% Base call accuracy ≥ 99%
Q30 >85% Base call accuracy ≥ 99.9%
Adapter contamination <5% Ensure clean reads for mapping
Tools: FastQC, Trimmomatic, Cutadapt

Step 2: Read Mapping and sgRNA Counting

Clean reads are aligned to the sgRNA reference library to determine how many reads map to each sgRNA. The mapping rate (percentage of reads matching the library) is calculated at this step.【Important: A low mapping rate alone does not compromise result reliability, as long as the absolute number of mapped reads maintains adequate sequencing depth (≥200× per sgRNA). The required data volume can be estimated as:Required Data Volume = Sequencing Depth × Library Coverage × Number of sgRNAs / Mapping Rate】
For a human whole-genome knockout library (~77,000 sgRNAs) with 200× depth and 500× coverage, approximately 10 Gb of sequencing data per sample is needed.
Tools: MAGeCK count, bowtie2

Step 3: Normalization and Quality Assessment

Raw sgRNA counts are normalized to account for differences in sequencing depth between samples. Common normalization methods include:
• Median normalization (default in MAGeCK): Adjusts counts so that the median sgRNA count is equal across samples
• Control sgRNA normalization: Uses non-targeting or safe-targeting sgRNAs as reference Quality assessment at this stage includes:
• Pearson correlation between biological replicates (target: r > 0.8)
• Principal Component Analysis (PCA) to check sample clustering
• Read count distribution (boxplots) to identify outliers

Step 4: Differential Analysis with MAGeCK RRA

The MAGeCK RRA (Robust Rank Aggregation) algorithm is the most widely used method for comparing sgRNA abundance between two conditions. It:
1. Calculates log-fold change (LFC) for each sgRNA
2. Ranks sgRNAs by LFC
3. Aggregates sgRNA-level rankings to gene-level scores using the RRA algorithm
4. Outputs gene-level p-values and FDR (false discovery rate)
Key output columns from MAGeCK RRA:
Column Meanin
Gene >pos.score
neg >pos.pvalue
neg >pos.fdr
neg >pos.lfc
neg >pos.rank
Example 1: RRA Analysis — mageck test
bash 
# Step 1: count sgRNA reads from FASTQ files
mageck count -l library.txt \
  -n my_screen \
  --sample-label day0,day14 \
  --fastq day0_R1.fastq,day14_R1.fastq

# Step 2: RRA test – treatment (day14) vs control (day0)
mageck test -k my_screen.count.txt \
  -t day14 \
  -c day0 \
  -n my_screen_results
Example 2: MLE Analysis — mageck mle
bash 
# Step 1: count sgRNA reads from FASTQ files (same as Example 1)
mageck count -l library.txt \
  -n my_screen \
  --sample-label day0,day14 \
  --fastq day0_R1.fastq,day14_R1.fastq

# Step 2: MLE analysis with a design matrix
mageck mle -k my_screen.count.txt \
  -d design_matrix.txt \
  -n my_screen_mle
已复制到剪贴板

Step 5: Candidate Gene Selection (Top 20 Approach)

After MAGeCK analysis, you need to select candidate genes for validation. Two common strategies:
Strategy A: RRA Rank-Based Selection
• Select the top 20–30 genes by RRA rank
• Advantage: Comprehensive integration of multiple sgRNA signals
• Example: Wang et al. identified Cop1 as a target by selecting top-ranked genes from RRA analysis
Strategy B: LFC + p-value Threshold
• Set explicit cutoffs, e.g., p-value < 0.01 and |LFC| > 1
• Advantage: Transparent, reproducible criteria
• Example: Guo et al. identified CDC7 using p < 0.01 and LFC ≤ -2
Recommended approach: Use RRA rank as the primary selection method, then cross-reference with LFC and p-value thresholds for secondary filtering. Selecting approximately **20 candidate proteins** from each screen provides a manageable set for downstream Venn diagram comparison and experimental validation.【The exact top-N threshold (10 vs. 20 vs. 30) should be tuned to library type: genome-wide libraries can afford a larger N, while focused libraries may use a smaller N. This is a practical convention rather than a statistically derived rule.】

03
How to Compare CRISPR Screen Results with Venn Diagrams

Why Venn Diagrams Matter in CRISPR Screen Analysis

When you run multiple CRISPR screens—whether across different cell lines, treatment conditions, time points, or analysis methods—you need to answer a critical question: Which candidate genes are consistently identified across screens?
Venn diagrams solve this problem by visually representing:
• Intersection (overlap): Genes identified in multiple screens—high-confidence targets
• Unique hits: Genes found in only one screen—potentially condition-specific or false positives
• Union: All candidate genes across all screens
This is particularly valuable when comparing the top 20 proteins from each screen, as the intersection set represents the most robust candidates for downstream validation.

Scenario: Comparing Top 20 Proteins Across Multiple Screens

Consider a typical research scenario:
1. Screen A: CRISPR knockout screen in Cell Line A → top 20 candidate proteins identified
2. Screen B: CRISPR knockout screen in Cell Line B → top 20 candidate proteins identified
3. Screen C: CRISPR knockout screen under different treatment → top 20 candidate proteins identified
A Venn diagram intersection of these three sets reveals:
• Genes common to all three screens (highest confidence shared targets)
• Genes shared between two screens (condition-dependent targets)
• Genes unique to each screen (context-specific targets)
This intersection analysis is widely used in published CRISPR screening studies. For example:
• Daniloski et al. (2020) used Venn diagrams to compare SARS-CoV-2 host factor screens at 33°C vs. 37°C, identifying both shared and temperature-specific host dependency factors
• Abe et al. (2023) used Venn diagrams to compare hits from two independent CRISPR screens (DDX11-KO and ESCO2-mut), revealing synthetic lethal genes including PAXIP1-PAGR1
• Chen et al. (2024) intersected CRISPR screening data with DEGs and survival-related genes using Venn diagrams to identify 41 key genes in papillary renal cell carcinoma

Tools for Generating Venn Diagrams from CRISPR Screen Hits

Tool TPlatform Best For Max Sets
**BioVenn** Web (biovenn.nl) Quick 2–3 set comparison 3
**VennDiagram (R)** R package Publication-quality diagrams 5
**matplotlib-venn (Python)** Python library Automated pipelines 3
**MAGeCK-VISPR** >Web interface Integrated CRISPR analysis Multiple
**caRpools (R)** >R package Built-in CRISPR screen Venn 3
**ggVennDiagram (R)** >R package Modern,customizable visualization 6
**InteractiVenn** >Web 2–6 set comparison 6
04
Interpreting Venn Diagram Intersections: Best Practices

What the Overlap Tells You

The intersection region of a Venn diagram—where multiple screen hit sets overlap—represents genes that are consistently identified as hits regardless of experimental condition. These are your highest-confidence candidate targets for several reasons:
1. Reproducibility: Genes found in multiple independent screens are less likely to be false positives
2. Robustness: Consistent hits across different conditions suggest fundamental biological roles rather than condition-specific artifacts
3. Statistical power: The intersection effectively combines evidence from multiple experiments, increasing confidence
When comparing 20 proteins from each screen, an intersection of 10–15 genes typically indicates good screen concordance. An intersection of fewer than 5 genes may suggest:
• High biological variability between conditions
• Insufficient selection pressure in one or more screens
• Technical issues in screen execution

What the Non-Overlapping Hits Mean

Genes found in only one screen (unique hits) are not necessarily false positives. They may represent:
• Condition-specific dependencies: Genes essential only under particular cellular contexts
• Synthetic lethal interactions: Genes whose knockout is lethal only in specific genetic backgrounds
• Technical noise: Random variation in sgRNA representation

To distinguish true condition-specific hits from noise, validate unique hits individually through independent knockout experiments.

Common Pitfalls in Intersection Analysis

Pitfall Consequence Solution
Using different hit selection criteria across screens Biased comparison Standardize thresholds (e.g., always top 20 by RRA rank)
Comparing screens with vastly different quality False intersections Ensure all screens pass QC (mapping rate, depth, replicate correlation)
Ignoring screen direction (positive vs. negative) Meaningless overlap Separate enrichment and depletion hits before comparison
Over-interpreting small overlaps False confidence Use permutation testing to assess statistical significance of overlap
Not accounting for library size differences Inflated/deflated overlap Normalize to comparable gene lists before intersection
05
Choosing the Right Analysis Tools for CRISPR Screens

✅MAGeCK (RRA and MLE)

MAGeCK (Model-based Analysis of Genome-wide CRISPR-Cas9 Knockout) is the industry standard for CRISPR screen data analysis. It provides two complementary algorithms:
• RRA (Robust Rank Aggregation): For pairwise comparisons (one treatment vs. one control). Ranks genes based on sgRNA abundance changes. The smaller the RRA score and the higher the rank, the more likely the gene is to be a target gene.
• MLE (Maximum Likelihood Estimation): For multi-condition modeling. Enables joint analysis of multiple experimental conditions with improved statistical power.

✅MAGeCK-VISPR

MAGeCK-VISPR extends MAGeCK with an integrated visualization framework. It provides:
• Interactive quality control plots
• Automatic Venn diagram generation for cross-comparison
• Beta score calculation for gene essentiality
• Web-based interface for non-programmatic users

✅caRpools

caRpools is an R package specifically designed for pooled CRISPR screen analysis. It includes:
• Built-in support for MAGeCK, DESeq2, and Wilcoxon test
• Automatic Venn diagram generation comparing hits from different methods
• Integrated visualization tools

✅DrugZ

DrugZ is particularly useful for analyzing CRISPR screens with drug treatment conditions. It uses a modified z-score approach to identify enriched and depleted sgRNAs, and is commonly used alongside MAGeCK for cross-validation.

Tool Comparison Table

Feature MAGeCK RRA MAGeCK MLE MAGeCK-VISPR caRpools DrugZ
**Comparison type** Pairwise Multi-condition Both Both Pairwise
**Statistical method** RRA MLE RRA + MLE Multiple Z-score
**Venn diagram** No No Yes (built-in) Yes (built-in) No
**Visualization** Limited Limited Rich (web) Moderate Limited
**Ease of use** Command line Command line Web + CLI R Command line
**Best for** Standard screens Complex designs Integrated analysis Method comparison Drug screens
06
Statistical Considerations for Reliable Hit Identification

RRA Score vs. LFC + p-value: Which to Use?

The RRA algorithm integrates multiple sgRNA-level metrics into a composite gene-level score, providing a comprehensive ranking. In contrast, combining LFC and p-value thresholds offers explicit cutoffs but may include more false positives.
Recommendation: Use RRA rank-based selection as your primary strategy. Cross-reference with LFC and p-value for secondary filtering. Both approaches are widely used in published literature, and combining them provides complementary insights.

Handling Biological Replicates

When multiple biological replicates are available:
• High reproducibility (Pearson r > 0.8): Perform combined analysis across all replicates to maximize statistical power
• Low reproducibility (Pearson r < 0.8): Perform pairwise comparisons, then use Venn diagram intersection to identify consistently overlapping hits across replicates
This Venn diagram approach to replicate comparison is specifically recommended when screen-to-screen variability is high, as it focuses on the most robust, reproducible targets.

Managing False Positives and False Negatives

• Reduce false positives: Require hits to appear in the intersection of at least two independent screens or analysis methods
• Reduce false negatives: Use relaxed thresholds (e.g., top 50 instead of top 20) for the initial selection, then narrow down through intersection analysis
• FACS-based screens: Be especially cautious—single-round enrichment screens have higher false positive/negative rates. Increase initial cell numbers and perform multiple sorting rounds where feasible
07
CRISPR Screen Data Analysis

Each sample should achieve a sequencing depth of at least 200×. For a human whole-genome knockout library (~77,000 sgRNAs), this translates to approximately 10 Gb of sequencing data per sample. The formula is: Required Data = Sequencing Depth × Library Coverage × Number of sgRNAs / Mapping Rate.

The intersection of a Venn diagram shows genes (or proteins) that are consistently identified as hits across multiple screens, conditions, or analysis methods. These overlapping genes represent your highest-confidence candidate targets, as they are reproducible across independent experiments.

Select the top 20 candidate genes from each screen (using RRA rank or LFC + p-value criteria), then use tools like Python's matplotlib-venn, R's VennDiagram or ggVennDiagram, or web tools like BioVenn to generate the Venn diagram. The intersection region reveals shared targets; unique regions show condition-specific hits.

A low mapping rate per se does not compromise reliability, as downstream analysis uses only mapped reads. However, the absolute number of mapped reads must maintain adequate sequencing depth (≥200× per sgRNA). Insufficient data volume, not low mapping rate, is the real concern.

Use RRA for simple pairwise comparisons (one treatment vs. one control). Use MLE when you have multiple experimental conditions that need joint modeling. MLE provides greater statistical power for complex experimental designs but requires more sophisticated setup.

Gene editing efficiency varies based on sgRNA sequence properties, chromatin accessibility, and off-target effects. Some sgRNAs may show little to no activity. Designing at least 3–4 sgRNAs per gene mitigates this variability and ensures more robust gene-level results.

Include well-validated positive control genes in your library. If these controls are significantly enriched (or depleted) in the expected direction, your screening conditions were effective. Without positive controls, assess cellular response (cell killing/survival) and examine bioinformatics outputs like LFC distribution and replicate correlation.

Popular options include: BioVenn (web-based, up to 3 sets), VennDiagram and ggVennDiagram (R packages, up to 5–6 sets), matplotlib-venn (Python, up to 3 sets), MAGeCK-VISPR (integrated analysis platform), and caRpools (R package with built-in CRISPR screen Venn diagram support).

The absence of significant gene enrichment is usually caused by insufficient selection pressure rather than statistical analysis errors. Try increasing selection pressure and/or extending the screening duration to enhance the signal-to-noise ratio.

If replicate correlation is high (Pearson r > 0.8), combine all replicates for a single analysis. If correlation is low, perform pairwise comparisons and use Venn diagram intersection analysis to identify consistently overlapping candidate genes across experiments.

Yes. Cross-method Venn diagrams are valuable for assessing result robustness. Genes identified by multiple methods are high-confidence hits. The caRpools R package has built-in functionality for generating Venn diagrams comparing MAGeCK, DESeq2, and Wilcoxon test results.

Negative screening uses mild selection pressure to identify genes whose knockout causes cell death or reduced viability (depleted sgRNAs). Positive screening uses strong selection pressure to identify genes whose knockout confers resistance or survival advantage (enriched sgRNAs).

08
Conclusion and Recommendations
CRISPR screen data analysis is a multi-step process that transforms raw sequencing reads into actionable biological insights. The key steps—quality control, read mapping, normalization, differential analysis with MAGeCK RRA, and candidate gene selection—each play a critical role in ensuring reliable results.
When comparing CRISPR screen results across multiple conditions, Venn diagram intersection analysis of the top 20 candidate proteins provides a powerful method for identifying high-confidence, reproducible targets. The intersection set represents genes consistently identified across independent screens, making them the strongest candidates for downstream validation.
Best practices summary:
1. Maintain ≥200× sequencing depth per sgRNA
1. Use MAGeCK RRA as your primary analysis tool
2. Select top 20–30 candidate genes by RRA rank
3. Compare results across screens using Venn diagrams
4. Prioritize intersection genes for experimental validation
5. Validate unique hits individually to identify condition-specific targets
6. Use standardized selection criteria across all screens being compared
By following this workflow, researchers can significantly reduce false positives and false negatives, improve the reproducibility of their findings, and accelerate the path from screen to validated target.

Related Service

CRISPR Library Screening

Related Product

Cat.No. Product Name Species Order Now
EDCLV0001-K01-A Human GeCKO Library Lentiviral sgRNA Library v2 (LentiCRISPR)（A） Human Order
EDCLV0001-K01-B Human GeCKO Library Lentiviral sgRNA Library v2 (LentiCRISPR)（B） Human Order
EDCLV0002-K02 Human CRISPR Knockout Pooled Library (Brunello) Human Order
EDCLV0003-K03 Mouse CRISPR Knockout Pooled Library (Brie) Mouse Order
EDCLV0004-K04 Bassik lab Human CRISPR-Cas9 Deletion Library - Proteostasis Human Order
EDCLV0005-K05 Bassik lab Human CRISPR-Cas9 Deletion Library - Apoptosis and cancer Human Order
EDCLV0006-K06 Bassik lab Human CRISPR-Cas9 Deletion Library - Gene Expression Human Order
EDCLV0007-K07 Bassik lab Human CRISPR-Cas9 Deletion Library - Membrane proteins Human Order
EDCLV0008-K08 Bassik lab Human CRISPR-Cas9 Deletion Library - Trafficking, mitochondrial, motility Human Order
EDCLV0009-K09 Bassik lab Human CRISPR-Cas9 Deletion Library - Drug targets, kinases, phosphatases Human Order
EDCLV0010-K10 Bonifacino Lab Human Ubiquitination-Related Proteins CRISPR Knockout Library Human Order
EDCLV0011-K11 The Human Druggable CRISPR Library Human Order
EDCLV0012-K12 Human Kinome CRISPR Knockout Pooled Libraries (Brunello). Human Order
EDCLV0013-K13 Yeo Lab RNA-Binding Protein Pooled CRISPR Knockout Library。 Human Order
EDCLV0014-K14 Human Epigenetic Knockout Library Human Order
EDCLV0015-K15 Human Lipid Droplet f fd Metabolism Library Human Order
EDCLV0016-K16 Human Transcription Factor Knockout Library Human Order
EDCLV0017-K17 Mouse Validation (mVAL) CRISPR Library Mouse Order
EDCLV0018-K18-A Mouse CRISPR Deletion Library - Apoptosis and cancer(A) Mouse Order
EDCLV0018-K18-B Mouse CRISPR Deletion Library - Apoptosis and cancer(B) Mouse Order
EDCLV0019-K19-A Mouse CRISPR Deletion Library - Drug targets, kinases, phosphatases(A) Mouse Order
EDCLV0019-K19-B Mouse CRISPR Deletion Library - Drug targets, kinases, phosphatases(B) Mouse Order
EDCLV0020-K20 Mouse CRISPR Deletion Library - Gene expression Mouse Order
EDCLV0021-K21-A Mouse CRISPR Deletion Library - Membrane proteins Mouse Order
EDCLV0022-K22 Mouse CRISPR Deletion Library - Stress proteostasis Mouse Order
EDCLV0023-K23 Mouse CRISPR Deletion Library - Trafficking, mitochondrial, motility Mouse Order
EDCLV0024-K24 Mouse CRISPR Metabolic Gene Knockout Library Mouse Order
EDCLV0025-K25 Mouse Kinome CRISPR Knockout Library (Brie) Mouse Order
EDCLV0026-K26 Human CRISPR Metabolic Gene Knockout Library Human Order
EDCLV0027-K27 Human Kinome CRISPR Knockout Library 1-4(Brunello) . Human Order
EDCLV0028-K28 Mouse messenger-RBP sgRNA Library（Turner Lab） Mouse Order
EDCLV0057-K29 Human Improved Genome-wide Knockout CRISPR Library Human Order
EDCLV0058-K30 Mouse Improved Genome-wide Knockout CRISPR Library v2 Mouse Order
EDCLV0060-K31 Mouse CRISPR Knockout Pooled Library (Brie)-#73632, cas9 Mouse Order
EDCLV0063-K32 Human CRISPR Knockout Pooled Libraries (Enriched Sub-pools)Ribosomal protein #51045 Human Order
EDCLV0021-K21-B Mouse CRISPR Deletion Library - Membrane proteins（B） Mouse Order
EDCLV0065-K34 Human CRISPR Knockout-gRNA pooled library in lentiCRISPRv2(Brunello) Human Order
EDCLV0068-I14 Human Paired-Guide RNA (pgRNA) Library for Long Non-coding RNAs (lncRNAs) #89640LncRNA Human Order
EDCLV0030-A02 Mouse CRISPR Activation Library (SAM 3-Plasmid System) Mouse Order
EDCLV0031-A03 Human Subpooled CRISPRa-v2 Libraries-Kinases, Phosphatases, and Drug Targets - gRNA pooled library Human Order
EDCLV0032-A04 Human CRISPR Activation Pooled Library (Calabrese P65-HSF) Human Order
EDCLV0033-A04 Human CRISPRa sgRNA library Calabrese in backbone XPR_502 (P65 HSF) Human Order
EDCLV0034-A05 Human CRISPR lncRNA Activation Pooled Library (SAM 3-Plasmid System) Human Order
EDCLV0035-A06 Human Genome-Wide CRISPRa-v2 Libraries-(top 5 sgRNAs/gene) Human Order
EDCLV0036-A07 Human Subpooled CRISPRa-v2 Libraries-Cancer and Apoptosis (h2), top 5 sgRNAs/gene Human Order
EDCLV0037-A08 Human Subpooled CRISPRa-v2 Libraries-Gene Expression (h5), top 5 sgRNAs/gene Human Order
EDCLV0039-A10 Mouse Genome-wide CRISPRa v2 Libraries-top 5 sgRNAs/gene Mouse Order
EDCLV0040-A11 Mouse Genome-wide CRISPRa v2 Libraries-Membrane Proteins (m6), top 5 sgRNAs/gene Mouse Order
EDCLV0041-A12 Human Genome-Wide CRISPRa-v2 Libraries-10 sgRNAs/gene Human Order
EDCLV0042-A13 mCRISPRa-v2, genome-wide, 10 sgRNAs/gene Mouse Order
EDCLV0043-A14 mCRISPRa-v2, Kinases, Phosphatases, and Drug Targets (m1), top 5 sgRNAs/gene Mouse Order
EDCLV0044-A15 Human SAM library in lentiSAMv2 backbone Human Order
EDCLV0045-A16 Human SAM Library in lenti sgRNA(MS2)_zeo backbone Human Order
EDCLV0055-A17 Human CRISPR Activation Library (SAM - 3 plasmid system) Human Order
EDCLV0056-A18 Mouse Metabolic Gene CRISPRa sgRNA Library Mouse Order
EDCLV0062-A19 Human Subpooled CRISPRa-v2 Libraries- Membrane Proteins (h6), top 5 sgRNAs/gene Human Order
EDCLV0064-K33 Human SAM library in lentiSAMv2 backbone #1000000078 (#75117) Human Order
EDCLV0047-I02 Human Subpooled CRISPRi-v2 Libraries-Cancer and Apoptosis (h2), top 5 sgRNAs/gene Human Order
EDCLV0048-I03 Human Subpooled CRISPRi-v2 Libraries-Stress and Proteostasis (h3), top 5 sgRNAs/gene Human Order
EDCLV0049-I04 Human Subpooled CRISPRi-v2 Libraries- Gene Expression (h5), top 5 sgRNAs/gene Human Order
EDCLV0051-I06 Mouse Genome-wide CRISPRi v2 Library-genome-wide, top 5 sgRNAs/gene Mouse Order
EDCLV0052-I07 Mouse Subpooled CRISPRi v2 Libraries-Membrane Proteins Mouse Order
EDCLV0053-I08 hCRISPRi-v2, Mitochondria, Trafficking, and Motility (h4), top 5 sgRNAs/gene Human Order
EDCLV0054-I09 hCRISPRi-v2, Kinases, Phosphatases, and Drug Targets (h1), top 5 sgRNAs/gene Human Order
EDCLV0059-I10-A Human CRISPR Inhibition Pooled Library (Dolcetto)(A) Human Order
EDCLV0059-I10-B Human CRISPR Inhibition Pooled Library (Dolcetto)(B) Human Order
EDCLV0061-I11 Human Subpooled CRISPRi-v2 Libraries-Membrane Proteins #83976 Human Order
EDCLV0065-I12 Human Genome-Wide CRISPRi-v2 Libraries Human Order
EDCLV0041 Human CRISPR Inhibition Pooled Library (Dolcetto) Order
EDCLVS0001-K01-A Human GeCKO Library Lentiviral sgRNA Library v2 (LentiCRISPR)（A） Human Order
EDCLVS0001-K01-B Human GeCKO Library Lentiviral sgRNA Library v2 (LentiCRISPR)（B） Human Order
EDCLVS0003-K03 Mouse CRISPR Knockout Pooled Library (Brie) Mouse Order
EDCLVS0005-K05 Bassik lab Human CRISPR-Cas9 Deletion Library - Apoptosis and cancer Human Order
EDCLVS0007-K07 Bassik lab Human CRISPR-Cas9 Deletion Library - Membrane proteins Human Order
EDCLVS0008-K08 Bassik lab Human CRISPR-Cas9 Deletion Library - Trafficking, mitochondrial, motility Human Order
EDCLVS0009-K09 Bassik lab Human CRISPR-Cas9 Deletion Library - Drug targets, kinases, phosphatases Human Order
EDCLVS0010-K10 Bonifacino Lab Human Ubiquitination-Related Proteins CRISPR Knockout Library Human Order
EDCLVS0013-K13 Yeo Lab RNA-Binding Protein Pooled CRISPR Knockout Library。 Human Order
EDCLVS0015-K15 Human Lipid Droplet f fd Metabolism Library Human Order
EDCLVS0016-K16 Human Transcription Factor Knockout Library Human Order
EDCLVS0018-K18-A Mouse CRISPR Deletion Library - Apoptosis and cancer(A) Mouse Order
EDCLVS0018-K18-B Mouse CRISPR Deletion Library - Apoptosis and cancer(B) Mouse Order
EDCLVS0019-K19-A Mouse CRISPR Deletion Library - Drug targets, kinases, phosphatases(A) Mouse Order
EDCLVS0019-K19-B Mouse CRISPR Deletion Library - Drug targets, kinases, phosphatases(B) Mouse Order
EDCLVS0020-K20 Mouse CRISPR Deletion Library - Gene expression Mouse Order
EDCLVS0022-K22 Mouse CRISPR Deletion Library - Stress proteostasis Mouse Order
EDCLVS0023-K23 Mouse CRISPR Deletion Library - Trafficking, mitochondrial, motility Mouse Order
EDCLVS0025-K25 Mouse Kinome CRISPR Knockout Library (Brie) Mouse Order
EDCLVS0026-K26 Human CRISPR Metabolic Gene Knockout Library Human Order
EDCLVS0027-K27 Human Kinome CRISPR Knockout Library 1-4(Brunello) . Human Order
EDCLVS0028-K28 Mouse messenger-RBP sgRNA Library（Turner Lab） Mouse Order
EDCLVS0057-K29 Human Improved Genome-wide Knockout CRISPR Library Human Order
EDCLVS0058-K30 Mouse Improved Genome-wide Knockout CRISPR Library v2 Mouse Order
EDCLVS0060-K31 Mouse CRISPR Knockout Pooled Library (Brie)-#73632, cas9 Mouse Order
EDCLVS0063-K32 Human CRISPR Knockout Pooled Libraries (Enriched Sub-pools)Ribosomal protein #51045 Human Order
EDCLVS0002-K02 Human CRISPR Knockout Pooled Library (Brunello) Human Order
EDCLVS0004-K04 Bassik lab Human CRISPR-Cas9 Deletion Library -
Proteostasis		 Human Order
EDCLVS0006-K06 Bassik lab Human CRISPR-Cas9 Deletion Library - Gene Expression Human Order
EDCLVS0011-K11 The Human Druggable CRISPR Library Human Order
EDCLVS0012-K12 Human kinome CRISPR knockout pooled libraries（A、B） Human Order
EDCLVS0014-K14 Human Epigenetic Knockout Library Human Order
EDCLVS0017-K17 Mouse Validation (mVAL) CRISPR Library Mouse Order
EDCLVS0021-K21-A Mouse CRISPR Deletion Library - Membrane proteins Mouse Order
EDCLVS0021-K21-B Mouse CRISPR Deletion Library - Membrane proteins Mouse Order
EDCLVS0024-K24 Mouse CRISPR Metabolic Gene Knockout Library Mouse Order
EDCLVS0034-A05 Human CRISPR lncRNA Activation Pooled Library (SAM 3-Plasmid System) Human Order
EDCLVS0036-A07 Human Subpooled CRISPRa-v2 Libraries-Cancer and Apoptosis (h2), top 5 sgRNAs/gene Human Order
EDCLVS0037-A08 Human Subpooled CRISPRa-v2 Libraries-Gene Expression (h5), top 5 sgRNAs/gene Human Order
EDCLVS0039-A10 Mouse Genome-wide CRISPRa v2 Libraries-top 5 sgRNAs/gene Mouse Order
EDCLVS0040-A11 Mouse Genome-wide CRISPRa v2 Libraries-Membrane Proteins (m6), top 5 sgRNAs/gene Mouse Order
EDCLVS0041-A12 Human Genome-Wide CRISPRa-v2 Libraries-10 sgRNAs/gene Human Order
EDCLVS0043-A14 mCRISPRa-v2, Kinases, Phosphatases, and Drug Targets (m1), top 5 sgRNAs/gene Mouse Order
EDCLVS0045-A16 Human SAM Library in lenti sgRNA(MS2)_zeo backbone Human Order
EDCLVS0062-A19 Human Subpooled CRISPRa-v2 Libraries- Membrane Proteins (h6), top 5 sgRNAs/gene Human Order
EDCLVS0030-A02 Mouse SAM Library in lenti sgRNA(MS2)_puro optimized backbone Mouse Order
EDCLVS0031-A03 hCRISPRa-v2, Kinases, Phosphatases, and Drug Targets (h1), top 5 sgRNAs/gene Human Order
EDCLVS0032-A04 Human CRISPRa sgRNA library Calabrese in backbone XPR_502 (P65 HSF) （A） Human Order
EDCLVS0033-A04 Human CRISPRa sgRNA library Calabrese in backbone XPR_502 (P65 HSF) （B） Human Order
EDCLVS0035-A06 hCRISPRa-v2, genome-wide, top 5 sgRNAs/gene（A） Human Order
EDCLVS0042-A13 mCRISPRa-v2, genome-wide, 10 sgRNAs/gene Mouse Order
EDCLVS0044-A15 Human SAM library in lentiSAMv2 backbone Human Order
EDCLVS0055-A17 Human CRISPR Activation Library (SAM - 3 plasmid system) Human Order
EDCLVS0056-A18 Mouse Metabolic Gene CRISPRa sgRNA Library Mouse Order
EDCLVS0048-I03 Human Subpooled CRISPRi-v2 Libraries-Stress and Proteostasis (h3), top 5 sgRNAs/gene Human Order
EDCLVS0051-I06 Mouse Genome-wide CRISPRi v2 Library-genome-wide, top 5 sgRNAs/gene Mouse Order
EDCLVS0052-I07 Mouse Subpooled CRISPRi v2 Libraries-Membrane Proteins Mouse Order
EDCLVS0053-I08 hCRISPRi-v2, Mitochondria, Trafficking, and Motility (h4), top 5 sgRNAs/gene Human Order
EDCLVS0059-I10-B Human CRISPR Inhibition Pooled Library (Dolcetto)(B) Human Order
EDCLVS0047-I02 hCRISPRi-v2, Cancer and Apoptosis (h2), top 5 sgRNAs/gene Human Order
EDCLVS0049-I04 hCRISPRi-v2, Gene Expression (h5), top 5 sgRNAs/gene Human Order
EDCLVS0054-I09 hCRISPRi-v2, Kinases, Phosphatases, and Drug Targets (h1), top 5 sgRNAs/gene Human Order
EDCLVS0059-I10-A Human CRISPR Inhibition Pooled Library (Dolcetto) Human Order

References

1. Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. *Genome Biol.* 15, 554 (2014).
1. Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. *Genome Biol.* 16, 281 (2015).
2. Wang, X. et al. In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target. *Cell* 184, 5357–5374 (2021).
3. Deng, L. et al. Identifying CDC7 as a synergistic target of chemotherapy in resistant small-cell lung cancer via CRISPR/Cas9 screening. *Cell Death Discov.* 9, 40 (2023).
4. Daniloski, Z. et al. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. *bioRxiv* (2020).
5. Abe, T. et al. CRISPR screens in sister chromatid cohesion defective cells reveal PAXIP1-PAGR1 as regulator of chromatin association of cohesin. *Nat. Commun.* (2023).
6. Hulsen, T. et al. BioVenn—a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. *BMC Genomics* 9, 488 (2008).
7. Kolde, R. et al. Robust rank aggregation for gene list integration and meta-analysis. *Bioinformatics* 28, 573–580 (2012).
8. Guo, L. et al. CRISPR Screen Identifies the RNA-Binding Protein Eef1a1 as a Key Regulator of Myogenesis. *Int. J. Mol. Sci.* 25, 4816 (2024).
9. Doench, J.G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. *Nat. Biotechnol.* 34, 184–191 (2016).

Contact us

+ 833-226-3234 (USA Toll-free)
+1-224-345-1927 (USA)
info@editxor.com

Tag
Previous
Next

Leave a Reply

Your email address will not be published.Required Fields are marked

Recent Promotions

Recent Post

Contact Us
*
*
*
*
How did you hear about us：
✖ service online